Failure to Find DUP25 in Patients with Anxiety Disorders, in Control Individuals, or in Previously Reported Positive Control Cell Lines

This source preferred by Andrew Mayers

Authors: Tabiner, M., Youings, S., Dennis, M., Baldwin, D.S., Buis, C., Mayers, A.G., Jacobs, P.A. and Crolla, J.A.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1180229/pdf/AJHGv72p535.pdf

Journal: American Journal of Human Genetics

Volume: 72

Pages: 535-538

ISSN: 1537-6605

Investigation of the co-occurrence of panic and phobic disorders with joint laxity led to the identification of various forms of interstitial duplications involving human chromosome 15q24-q26 (named “DUP25”) in a Spanish population. DUP25 was observed in 68 of 70 (97%) patients assigned the diagnosis panic disorder/agoraphobia. DUP25 was also found in 14 of 189 (7%) control individuals. In the present study, we replicated the experimental conditions described by Grataco` s and colleagues in which fluorescence in situ hybridization was used to examine metaphase chromosomes of patients with panic disorder/social phobia and of control individuals from a southern region of the United Kingdom, the primary aim being to determine the prevalence of this chromosomal rearrangement in a geographically and ethnically distinct population. DUP25 was not observed in any of our 16 patients or 40 control samples or in three previously reported DUP25-positive control (Centre d’Etude du Polymorphisme Humain) cell lines, indicating a highly significant difference in the frequency of DUP25 between the study by Grataco’s and colleagues and the present investigation.

The data on this page was last updated at 04:40 on August 20, 2017.